The enhanced capabilities allow IDT to produce high-diversity, low-yield oligonucleotides quickly and reliably, broadening options for research and commercial applications.
Danaher company, Integrated DNA Technologies (IDT), has announced it is expanding its DNA synthesis capabilities to support customer needs across yield, complexity, and scale, from rapid production of high-diversity designs in early development, to dependable manufacturing for larger, longer-term programs.
The expanded offering will enable IDT to produce low yield, high-diversity oligonucleotides with speed and scale, extending its extensive capabilities in high-yield, high-fidelity oligonucleotide production. Together, these capabilities strengthen IDT’s broad synthesis foundation, equipping customers with a full spectrum of DNA synthesis offerings to move faster, select the right solution as requirements evolve, and scale with the quality, consistency, and reliability their programs require.
